The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Anticancer Drug Development and Cancer Chemotherapy
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Anticancer Drug Development and Cancer Chemotherapy.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Anticancer Drug Development and Cancer Chemotherapy.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Anticancer Drug Development and Cancer Chemotherapy are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
19. International Conference on Anticancer Drug Development and Cancer Chemotherapy has teamed up with the Special Journal Issue on
Anticancer Drug Development and Cancer Chemotherapy.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
Energy Deposited by Secondary Electrons Generated by Swift Proton Beams through Polymethylmethacrylate
Maurizio Dapor, Isabel Abril, Pablo de Vera, Rafael Garcia-Molina
-
Wound Healing Dressing and Some Composites Such as Zeolite, TiO2, Chitosan and PLGA: A Review
L. B. Naves, L. Almeida
-
Synthesis of PVA/γ-Fe2O3 Used in Cancer Treatment by Hyperthermia
Sajjad Seifi Mofarah, S. K. Sadrnezhaad, Shokooh Moghadam, Javad Tavakoli
-
Application of Magnetic Circuit and Multiple-Coils Array in Induction Heating for Improving Localized Hyperthermia
Chi-Fang Huang, Xi-Zhang Lin, Yi-Ru Yang
Conference venue information will be released soon.
Anticancer drug development
Pharmacokinetic, pharmacodynamic, and pharmacogenetic principles
Cancer chemotherapy
Genotoxic therapy
Novel targets in the cell cycle and cell cycle checkpoints
Molecular regulation of cell cycle progression and checkpoints
Agents and strategies for therapeutic interference
Growth factor and signal transduction targets for cancer therapy
Nuclear hormone receptors as targets for cancer therapy
Implications for drug discovery and development
Cell death pathways as targets for anticancer drugs
Drug resistance pathways as targets
Cancer invasion and metastasis
Cell adhesion in cancer
Cancer cell motility
Inflammatory response to cancer
Proteolytic enzymes implicated in cancer invasion
Gene-directed enzyme prodrug therapy
Tumor antigens as targets for anticancer drug development
Structure-based drug design and its contributions to cancer chemotherapy
The contribution of synthetic organic chemistry to anticancer drug development
Development of synthetic compounds: structure–activity relationships
Immunotoxins: synthetic organic chemistry applied to large molecules
Organic synthesis in rational design
Biosynthetic products for anticancer drug design and treatment
DNA-encoded peptide libraries and drug discovery
High throughput screening for novel anticancer drug discovery
Importance of mechanism-based targets in postgenomic drug discovery
Tumor cell cultures in drug development
| Abstracts/Full-Text Paper Submission Deadline |
|
May 15, 2024 |
| Notification of Acceptance/Rejection |
|
May 30, 2024 |
| Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
February 28, 2025 |
| Conference Dates |
|
March 29-30, 2025 |
